West Nile Virus Cases Surge in France as Climate Change Accelerates Mosquito Spread

France's public health agency confirmed 161 cases of West Nile virus and five deaths by early October, marking an unprecedented surge for the country. The surveillance period runs from May through November each year, and the October 7 bulletin showed the outbreak accelerating—16 new cases reported in just the previous week. Of those 161 cases, 28 were caught incidentally during blood donation screening and showed no symptoms. The remaining 133 people experienced illness, and among them, 60 developed the severe neuro-invasive form of the disease, which can cause inflammation of the brain tissue or the membrane surrounding the spinal cord. The agency noted it cannot definitively attribute all five deaths to the virus itself, though the cases occurred during active infection.

This year's numbers dwarf what France saw in 2025, when the country recorded 62 cases and five deaths across the entire summer season. The virus arrives in humans through the bite of the common mosquito, Culex pipiens, which becomes infected after feeding on birds—either migratory species returning from Africa or birds that contracted the virus locally in Europe. Most people who catch West Nile virus never know they have it; roughly 80 percent of infections produce no symptoms at all. When symptoms do appear, they typically resemble the flu: fever, headache, body aches. In a small fraction of cases, the virus crosses into the nervous system and becomes life-threatening.

Yannick Simonin, a virologist at the University of Montpellier, told French public radio that the official count represents only a fraction of actual infections. He estimates the true number could be ten times higher. Many people with mild, flu-like symptoms never see a doctor, and even those who do may not receive a West Nile diagnosis. The virus has no commercial vaccine and no preventive treatment. There is no human-to-human transmission except in the rare event of blood transfusion or organ transplant. Humans and horses are what epidemiologists call dead-end hosts—they cannot pass the virus back to mosquitoes, even if bitten again.

The geographic reach has expanded dramatically. West Nile virus was first documented in France in the 1960s, confined mostly to the Mediterranean coast and endemic wetland areas like the Camargue. Over decades it spread inland, reaching the Nouvelle-Aquitaine region in 2022 and arriving in Île-de-France—the region containing Paris—in 2025. As of late September, France's veterinary agency recorded 364 symptomatic cases in horses and 18 in birds across eight regions. Across Europe, 15 countries reported more than 1,000 cases combined in 2026, with Italy accounting for a large share. Nearly 80 deaths have been documented across the continent, making West Nile the deadliest mosquito-borne virus circulating in Europe.

Climate change is the primary driver of this expansion. A severe drought gripped much of France during the summer of 2026, concentrating both mosquitoes and birds around the few remaining water sources. Mosquitoes breed in shallow pools and puddles; birds gather to drink. The closer contact between infected birds and hungry mosquitoes accelerated transmission. But heat does more than concentrate the vectors—it speeds their reproduction. At 25 degrees Celsius, a mosquito develops from egg to adult in eight to ten days. At 30 or 35 degrees, that cycle compresses to six or seven days. Warmer temperatures mean larger mosquito populations emerge faster, and they survive longer into the season.

Anna-Bella Failloux, a medical entomologist at the Institut Pasteur, explained that rising temperatures are also expanding the geographic range where mosquitoes can survive and breed. West Nile virus cases have now appeared in Germany and the Netherlands—temperate countries far from tropical zones. The virus is no longer confined to southern Europe. Simonin warned that the trend is inevitable: cases will continue to rise across the continent as climate patterns shift. He called for institutional-level surveillance and monitoring, particularly to understand which bird species are introducing the virus into new regions and which are maintaining it locally. He also stressed the need for better diagnostic tools, treatment protocols, and public health preparedness, as diseases once considered exotic are becoming routine across Europe.